Avohoidon Tutkimussäätiö

CurifyLabs is a Finnish healthtech company that specializes in developing 3D printing solutions for the personalized manufacturing of medicines within pharmacies and hospitals. Founded in 2021 by Charlotta Topelius and Niklas Sandler Topelius, the company offers an automated on-demand manufacturing system known as “the Pharma Kit,” along with printable pharmaceutical inks. This innovative approach enables the mass customization of medications tailored to individual patient needs, enhancing treatment efficacy and safety while significantly reducing costs. By streamlining the drug compounding process, CurifyLabs improves compliance and sustainability in pharmaceutical manufacturing, making personalized medicines readily available on-site in healthcare settings.

StemSight is a cell therapy startup based in Tampere, Finland, focused on developing innovative treatments for blindness. The company is creating an off-the-shelf cell therapy platform that utilizes induced pluripotent stem cells (iPSCs) and biomaterials. Its initial product aims to address limbal stem cell deficiency, a rare condition that affects vision. StemSight plans to expand its offerings to include therapies for more common forms of corneal blindness, with the ultimate goal of helping patients regain their sight.